Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl infusion versus on-demand morphine for refractory dyspnea in acute decompensated heart failure
2020-003971-16Phase 3Active
- Sponsor
- Fundació Assistencial de Mútua de Terrassa
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Fentanyl continuous parenteral infusion with Morphine on-demand bolus (2 arms). Primary endpoint: Decrease in average daily intensity of dyspnea. Started Sep 2021; status: active.
02
Drugs
fentanylmorphine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2020-003971-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003971-16.